sam patrick posted an articleKOR Medical Launches Consumer Line of CBD and Related Cannabinoid Products to Support Mental and Physical WellnessSouth Carolina Company Offers Free Personalized Support to Purchasers see more
Charleston-based health innovation company KOR Medical --which produces unique cannabinoid products designed to support physical and mental wellness through expert engineering coupled with an individualized approach -- launches its initial consumer product line of CBD, CBN and CBG product offerings across the United States today.
To celebrate its nationwide launch, KOR is offering up to 30% off the valued price of its KOR System Bundle – a curated collection of Health, Sleep, Calm and Relief sprays, strips, and transdermal cream. The special can be purchased 24/7 online at www.KORmedical.com by using discount code LAUNCHDEAL at checkout. Shipping is included on each KOR System bundle, and consumers can also order KOR products individually.
Aligning biology with science, KOR’s long-awaited and third-party tested Health, Sleep, Calm and Relief products include sprays, strips and transdermal cream which use a combination of various cannabinoids and advanced delivery techniques developed over years of research, analytics and testing to help consumers feel better both mentally and physically.
Citing the mental and physical strain on American consumers of the last two years, KOR Medical products utilize the transformative power of cannabinoids to support mental and physical wellness by delivering the right amount for the right individual at the right time. Consumers across America are embracing cannabinoids given their potential as an alternative solution.
KOR Medical has partnered with Leaf411™ to provide free, personalized support to customers, who can speak directly with a cannabis-trained registered nurse on cannabinoid use and applications.
KOR Medical’s sublingual sprays, sublingual strips, and transdermal cream are formulated for targeted relief and quick onset. All sublingual products are nano emulsified to accelerate absorption rate within the body.
All KOR Medical cannabinoid-based product offerings are manufactured in FDA-registered facilities and third-party lab-verified and represent the highest standards of science, innovation, patient experience, compliance, and customer service.
The cannabis flower has a rich history of usage in the neuropathic industry dating back thousands of years, and produces over 100 cannabinoids including CBN, CBG and CBD – each a key component is KOR Medical products, and with unique benefits and effects. Today, medical researchers are continuing to explore if these molecules can impact anxiety, insomnia, chronic pain, anti-inflammatory diseases, seizures, and such diseases as Alzheimer’s and Parkinson’s disease.
Visit KOR Medical at www.kormedical.com.
sam patrick posted an articleVikor Scientific Launches KOR Medical, Plans to “Set the Standard” in Personalized Clinical Cannabis TreatmentFormer SCBIO exec Sam Konduros to lead KOR Medical see more
Former SCBIO CEO Sam Konduros named President and Chief Executive Officer
of new Vikor Scientific health innovation company
CHARLESTON, SOUTH CAROLINA – May 4, 2021 – Continuing its rapid expansion as one of South Carolina’s fastest growing life sciences and healthcare firms, Charleston-headquartered Vikor Scientific announced that it is launching health innovation company KOR Medical “to set a new industry standard in the arena of personalized clinical cannabis to benefit patients afflicted with diseases ranging from epilepsy to cancer, and to help alleviate the nation’s opioid addiction crisis.”
According to KOR Medical Managing Partners and Vikor Scientific Co-Founders Scotty Branch and Shea Harrelson, the company is exploring locations nationwide for its initial state-of-the-art, multi-million-dollar operation.
“KOR Medical will be a highly innovative organization that will bring a new blueprint and novel value proposition to the national clinical cannabis marketplace, powered by an AI and blockchain supported seed to sale platform,” said Mr. Branch. “Coupled with a relentless commitment to personalized medicine and rigorous compliance and purity, KOR will focus on providing clinicians with the tools and data they need to support leading-edge treatment protocols for the needs of each unique patient.”
In addition to former South Carolina Biotechnology Industry Organization (SCBIO) chief executive Sam Konduros, a seasoned business leader and attorney who will serve as president and CEO, KOR Medical is also onboarding four senior executives that bring multi-disciplinary expertise and experience in the clinical cannabis industry – including Joseph Strauss, who will serve as COO and executive vice president. Mr. Strauss brings more than a decade of immersive experience in the industry across multiple states to KOR, including Oregon, California, Colorado, and Florida. Other corporate appointees championing sales and marketing, cultivation and innovation, and government and legal affairs will be announced in early Summer.
“Mr. Konduros will lead all aspects of the company’s business and serve on the board of directors of both KOR Medical and Vikor Scientific to provide insights regarding the strategic direction of our portfolio of companies as we expand in the US and globally,” said Mr. Branch. “Sam is the epitome of a world class CEO. We look forward to watching him execute our mission with the support of an extraordinary executive team who will enable KOR Medical to achieve its vision to help transform healthcare.”
Armed with a comprehensive business plan and finalization of its laboratory-grade indoor growing facility design, KOR Medical is currently forging key industry and business partnerships with numerous entities with established track records in the cannabis industry. KOR Medical expects to confirm its initial US location of operations by mid-Summer 2021, with the site becoming a model for future expansion across the nation. KOR is planning its initial product launch during 2021, followed by full-scale production in 2022.